Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1453)	12/12/2005 10:41:48 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NGEN Has closed some its earlier upgap. It announced today that it has expanded its molecular reagent product portfolio with two new products. biz.yahoo.com The stock needs to close above the November 8 H of 3.30 bigcharts.marketwatch.com The longer term chart remains interesting. <g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1453)	5/5/2006 3:53:14 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

PRCS Is having an spike today. bigcharts.marketwatch.com It is trying to get off from its nearterm downtrend coming from the March 5 H at 6.44 bigcharts.marketwatch.com It reported that the loss for the 1stQ was approximately $0.67/shr vs.$1.18/shr in 2005. The cut on the loss was due primarily to lower expenses as the revenues were 81% lower.<g> The cash at the end of the Q was down by $10M from the cash position at the start of the Q. The CEO said that theye are focusing their efforts on advancing the PPI-2458 which is on a PI trial in patients with non-Hodgkin's lymphoma and solid tumors. In March they made a deal with GILD to identify candidates for an antiviral target. The stock is selling around 0.9xBV The EL for 2006 is around $1.40/shr vs. the $2.90/shr loss in 2005. PRCS' LTC remains "interesting".<g> bigcharts.marketwatch.com Bernard